Inovio Pharmaceuticals, Inc. (INO) Worth Watching: Stock Surges 12.7% - Tale of the Tape

Inovio Pharmaceuticals, Inc. INO was a big mover last session, as the company saw its shares shoot up nearly 13% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $3.23 to $3.82 in the past one-month time frame, showed a pick-up yesterday at $3.64.

In the last 30 days, the company witnessed 1 upward and downward estimate revision each, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

Inovio Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some other stocks worth considering in the healthcare industry include Alexion Pharmaceuticals, Inc. ALXN and Aastrom Biosciences, Inc. ASTM with a Zacks Rank #1 (Strong Buy) along with Cambrex Corporation.CBM holding a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALEXION PHARMA ALXN: Free Stock Analysis Report

AASTROM BIOSCI ASTM: Get Free Report

CAMBREX CORP CBM: Free Stock Analysis Report

INOVIO PHARMAC INO: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs